Cargando…

Moderate Intensity Exercise in Pre-manifest Huntington’s Disease: Results of a 6 months Trial

BACKGROUND: While it has been shown that aerobic exercise interventions are well tolerated in participants with the Huntington disease (HD) gene mutation, no study to date has tested whether an aerobic exercise intervention benefits brain structure and function in pre-manifest HD. OBJECTIVE: In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aldine, Amro Saad, Ogilvie, Amy, Wemmie, John, Kent, James, Schultz, Jordan, Long, Jeffrey D., Kamholz, John, Sajjad, Hassan, Kline, Joel, Shaw, Emily, Voss, Michelle, Paulsen, Jane S., Magnotta, Vincent A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815110/ https://www.ncbi.nlm.nih.gov/pubmed/35128541

Ejemplares similares

Autonomic changes in Huntington’s disease correlate with altered central autonomic network connectivity
por: Schultz, Jordan L, et al.
Publicado: (2022)

3244 The Autonomic Nervous System as a Potential Therapeutic Target in Huntington Disease
por: Schultz, Jordan L, et al.
Publicado: (2019)

Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
por: Ogilvie, Amy C., et al.
Publicado: (2023)

Subcortical T1-Rho MRI Abnormalities in Juvenile-Onset Huntington’s Disease
por: Tereshchenko, Alexander V., et al.
Publicado: (2020)

Mild Cognitive Impairment as an Early Landmark in Huntington's Disease
por: Zhang, Ying, et al.
Publicado: (2021)

Comment on “Adult onset of ganglioneuroblastoma of the adrenal gland: case report and review of the literature”
por: Stevens, Christopher, et al.
Publicado: (2022)

Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease
por: Wijeratne, Peter A., et al.
Publicado: (2021)

Effect of Trinucleotide Repeats in the Huntington's Gene on Intelligence
por: Lee, Jessica K., et al.
Publicado: (2018)

Brain structure in juvenile-onset Huntington disease
por: Tereshchenko, Alexander, et al.
Publicado: (2019)

Atypical Imaging Findings of Nonketotic Hyperglycemic Hemichorea: A Case Report and Review of the Literature
por: Stevens, Christopher M, et al.
Publicado: (2023)

The Neurodevelopmental Hypothesis of Huntington’s Disease
por: van der Plas, Ellen, et al.
Publicado: (2020)

Cortical neurodevelopment in pre-manifest Huntington's disease
por: Kubera, Katharina M., et al.
Publicado: (2019)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients
por: Wang, Rui, et al.
Publicado: (2014)

Autonomic Changes in Juvenile-Onset Huntington’s Disease
por: Schultz, Jordan L., et al.
Publicado: (2020)

Dissociable Motivational Deficits in Pre-manifest Huntington’s Disease
por: Atkins, Kelly J., et al.
Publicado: (2020)

Sleep Quality and Related Clinical Manifestations in Huntington Disease
por: Maffi, Sabrina, et al.
Publicado: (2022)

Psychiatric manifestations of huntington’s disease: Two case reports
por: Göy, D., et al.
Publicado: (2021)

Proton Exchange Magnetic Resonance Imaging: Current and Future Applications in Psychiatric Research
por: Shaffer, Joseph J., et al.
Publicado: (2020)

Assessing Behavioural Manifestations Prior to Clinical Diagnosis of Huntington Disease: "Anger and Irritability" and "Obsessions and Compulsions"
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

4472 Plasma Neurofilament Light as a Biomarker for Pediatric Patients with Huntington’s Disease
por: Schultz, Jordan L
Publicado: (2020)

The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease
por: Rabinovich‐Guilatt, L., et al.
Publicado: (2015)

Relationship altered between functional T1ρ and BOLD signals in bipolar disorder
por: Shaffer, Joseph J., et al.
Publicado: (2017)

Cognitive Impairment and Neuropsychiatry Manifestation Following Mild and Moderate Traumatic Brain Injury at 3 Months and 6 Months
por: Othman, Aizzat, et al.
Publicado: (2022)

Oromandibular Dyskinesia as the Initial Manifestation of Late-Onset Huntington Disease
por: Oh, Dong-Seok, et al.
Publicado: (2011)

Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington’s Disease
por: Reyes, Alvaro, et al.
Publicado: (2018)

Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease
por: Coppen, Emma M, et al.
Publicado: (2019)

Time will tell: Decision making in premanifest and manifest Huntington’s disease
por: Heim, Beatrice, et al.
Publicado: (2020)

Changes in brain activity with tominersen in early-manifest Huntington’s disease
por: Hawellek, D J, et al.
Publicado: (2022)

Role of Early PET/CT Imaging with 68Ga-PSMA in Staging and Restaging of Prostate Cancer
por: Barakat, Andrew, et al.
Publicado: (2020)

Paraganglioma in a Young Adult Female Patient: A Case Report
por: Stevens, Christopher M, et al.
Publicado: (2023)

Molecule of the month: miRNA and Huntington's disease (HD)
por: Shapshak, Paul
Publicado: (2013)

Brain Abnormalities in Bipolar Disorder Detected by Quantitative T1ρ Mapping
por: Johnson, Casey P., et al.
Publicado: (2015)

Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntington’s Disease
por: Achenbach, Jannis, et al.
Publicado: (2022)

Longitudinal Change in Gait and Motor Function in Pre-manifest Huntington’s Disease
por: Rao, Ashwini K., et al.
Publicado: (2011)

Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease
por: Novak, Marianne J. U., et al.
Publicado: (2012)

Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease
por: Murueta-Goyena, Ane, et al.
Publicado: (2023)

Neurobiology of panic and pH chemosensation in the brain
por: Wemmie, John A.
Publicado: (2011)

Adrenal Ganglioneuroblastoma of Adult Onset: A Literature Review
por: Stevens, Christopher M, et al.
Publicado: (2023)

tDCS improves perceptions of fatigue in patients with Post-COVID-19-symptoms that are less than 6 months post-infection
por: Rudroff, Thorsten, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1tnsj5kjffa40fhf7bu647b823